THE THERAPEUTIC EFFECTS OF SINGING IN NEUROLOGICAL DISORDERS

被引:91
|
作者
Wan, Catherine Y.
Rueber, Theodor
Hohmann, Anja
Schlaug, Gottfried [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
来源
MUSIC PERCEPTION | 2010年 / 27卷 / 04期
关键词
singing; treatment; stuttering; Parkinson's disease; aphasia; autism; MELODIC INTONATION THERAPY; PARKINSONS-DISEASE; SPEECH; FREQUENCY; APHASIA; INTELLIGIBILITY; REDUCTION; MUSICIANS; ACCURACY; SPEAKING;
D O I
10.1525/MP.2010.27.4.287
中图分类号
J6 [音乐];
学科分类号
摘要
MUSIC MAKING ( PLAYING AN INSTRUMENT OR SINGING) is a multimodal activity that involves the integration of auditory and sensorimotor processes. The ability to sing in humans is evident from infancy, and does not depend on formal vocal training but can be enhanced by training. Given the behavioral similarities between singing and speaking, as well as the shared and distinct neural correlates of both, researchers have begun to examine whether singing can be used to treat some of the speech-motor abnormalities associated with various neurological conditions. This paper reviews recent evidence on the therapeutic effects of singing, and how it can potentially ameliorate some of the speech deficits associated with conditions such as stuttering, Parkinson's disease, acquired brain lesions, and autism. By reviewing the status quo, it is hoped that future research can help to disentangle the relative contribution of factors to why singing works. This may ultimately lead to the development of specialized or "gold-standard" treatments for these disorders, and to an improvement in the quality of life for patients.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 50 条
  • [21] Statins in Neurological Disorders: Mechanisms and Therapeutic Value
    Reiss, Allison B.
    Wirkowski, Elzbieta
    THESCIENTIFICWORLDJOURNAL, 2009, 9 : 1242 - 1259
  • [22] Therapeutic nanoplatforms and delivery strategies for neurological disorders
    You Jung Kang
    Eric Gerard Cutler
    Hansang Cho
    Nano Convergence, 5
  • [23] Therapeutic nanoplatforms and delivery strategies for neurological disorders
    Kang, You Jung
    Cutler, Eric Gerard
    Cho, Hansang
    NANO CONVERGENCE, 2018, 5
  • [24] Connexins as therapeutic targets in neurological and neuropsychiatric disorders
    Charveriat, M.
    Mouthon, F.
    Rein, W.
    Verkhratsky, A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2021, 1867 (05):
  • [25] Inflammasomes in neurological disorders — mechanisms and therapeutic potential
    Kishore Aravind Ravichandran
    Michael T. Heneka
    Nature Reviews Neurology, 2024, 20 : 67 - 83
  • [26] Emergence of taurine as a therapeutic agent for neurological disorders
    Jangra, Ashok
    Gola, Priyanka
    Singh, Jiten
    Gond, Pooja
    Ghosh, Swarnabha
    Rachamalla, Mahesh
    Dey, Abhijit
    Iqbal, Danish
    Kamal, Mehnaz
    Sachdeva, Punya
    Jha, Saurabh Kumar
    Ojha, Shreesh
    Kumar, Dinesh
    Jha, Niraj Kumar
    Chopra, Hitesh
    Tan, Shing Cheng
    NEURAL REGENERATION RESEARCH, 2024, 19 (01) : 62 - 68
  • [27] THERAPEUTIC POTENTIAL OF BOTULINUM TOXIN IN NEUROLOGICAL DISORDERS
    CLARKE, CE
    QUARTERLY JOURNAL OF MEDICINE, 1992, 82 (299): : 197 - 205
  • [28] Insights on therapeutic potential of clemastine in neurological disorders
    Jiang, Sufang
    Wang, Xueji
    Cao, Tianyu
    Kang, Rongtian
    Huang, Lining
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [29] Astrocytes: Emerging Therapeutic Targets in Neurological Disorders
    Valori, Chiara F.
    Guidotti, Giulia
    Brambilla, Liliana
    Rossi, Daniela
    TRENDS IN MOLECULAR MEDICINE, 2019, 25 (09) : 750 - 759
  • [30] Targeting pericytes for therapeutic approaches to neurological disorders
    Jinping Cheng
    Nils Korte
    Ross Nortley
    Huma Sethi
    Yamei Tang
    David Attwell
    Acta Neuropathologica, 2018, 136 : 507 - 523